EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
Interim clinical results from Project IMPACT: Diabetes, announced today by the American Pharmacists Association (APhA) Foundation, show statistically significant decreases in A1C or blood sugar levels, LDL cholesterol, systolic blood pressure and Body Mass Index (BMI), which are all recognized standards of diabetes care. Participating patients in 25 communities who experienced improved outcomes encompass almost every socioeconomic class, insurance status and ethnicity.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62268-american-pharmacists-association-apha-foundation-project-impact-diabetes
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
The largest-ever morbi-mortality study of treatments for chronic heart failure has shown that adding the specific heart rate lowering agent Procoralan® (ivabradine) to standard therapy significantly reduces the risk of death and hospitalisation for heart failure.1 Results from this new study, SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial), were presented today at the European Society of Cardiology1 in Stockholm and published in The Lancet.2
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shift/44195/
Thirty–nine percent of 12th–grade students have the mathematics skills and 38 percent the reading skills needed for entry–level college courses, according to results on the National Assessment of Educational Progress (NAEP), released today by the National Center for Education Statistics.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7226751-naep-national-scores-less-than-half-twelfth-graders-prepared-for-college
The Preeclampsia Foundation, the nation’s only non-profit patient advocacy organization for preeclampsia and related hypertensive disorders of pregnancy, today announced the results of a recent nationwide Preeclampsia Awareness Survey of more than 1,500 expectant and new mothers. These findings are driving the Foundation’s strategies associated with National Preeclampsia Awareness Month.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7171451-preeclampsia-foundation-awareness-survey-education-pregnancy-disorders
ARC is the first all-in-one content engagement platform that lets you easily, quickly and widely distribute your multimedia content – especially video - across multiple digital channels to all of your key audiences. Unlike widgets or microsites or passive media players, ARC brings together everything you need to drive content marketing results:
A highly accessible and interactive format. Massive distribution via PR Newswire’s industry-leading multimedia content distribution network. Dynamic, “on-the-fly” update-ability. Along with extreme speed, efficiency and measurability. No other digital platform does more to make your content marketing programs successfully deliver measurable results.
For more information, go to http://www.multivu.com/players/English/48198-PRNewswire-ARC-Marketing/
Pixee Fox, who has undergone many plastic surgeries from eye color implant to breast implant, butt lifting, and 6 ribs removal, travelled to Istanbul last week to be one step closer to her dream of becoming a cartoon character. Pixee shared the results of her Spider Web non surgical Face Lifting procedure, which was developed by Aesthetic Surgeon Bülent Cihantimur M.D.
Dr. Bülent Cihantimur, who listened to and examined Pixee Fox at his Istabul Byomed clinic prior to application, said: “Pixee was in need of a solution for her round face. She said she did not like her U shaped face and was looking for a V shaped contour line. Upon a friend’s recommendation, she went on my website and researched about Spider Web Face Lifting. After making contact, she came to Istanbul to undergo the Spider Web Face Lifting.”
Cihantimur contıunes: “The Spider Web Technique is a non-surgical procedure that shrinks, rejuvenates, and forms the face. In this technique I developed, fine needles are used to net medical threads that can dissolve just like a spider’s web under the skin. The body reacts to these threads and nets its own biological net around them. It boosts collagen production and increases lowered elastin.”
At the Goody\\\\\\\'s Fast Relief 500 at Martinsville Speedway in Virginia, the friendly rivalry between racing legend and Goody\\\'s spokesman Richard Petty, and country music superstar and BC Powder spokesman Trace Adkins, got serious for two very good causes. Victory Junction, chosen by Petty, and Adkins\\\\\\\' chosen charity, Wounded Warrior Project, each received a donation of $50K from the powder brand they represent. Last year, BC and Goody\\\\\\\'s launched their joint Pick A Powder Campaign (www.pickapowder.com) to see which powder is the fastest at getting rid of pain. While the rivalry led by their respective spokesmen remains neck and neck, today\\\\\\\'s truce resulted in a total donation of $100,000.
Some say that when China sneezes the rest of the world catches cold, but the biggest luxury brands are catching on in China, becoming the most exclusive and desirable ones in fashion according to the wealthiest Chinese women. Still, our ranking also reveals a stronger competition that is accentuated by the wealthy customers’ increasingly stronger maturity. This barometer Promise Consulting / BNP Exane classifies the 15 most exclusive and desirable brands in China in the universe of feminine Fashion. This Barometer is conducted amongst the wealthiest Chinese women, and is about the 30 luxury brands in ready-to-wear/handbags/shoes/accessories that have invested the most in communication (source: Industry Interviews, Exane Paribas). Promise and BNP Exane already conducted the same survey amongst French women in May 2015 (http://bit.ly/1ESTZGu).
”This barometer in association with BNP Exane reflects our determination to move closer to the marketing and cross-section financial analysis. Our Monitoring Brand Assets® approach itself features very complementary analyzes with those conducted by BNP Exane’s experts. Hence, the obtained results from our joined barometer are based on two different angles of expertise, marketing and financial, which brings a unique added value to the managers and decision-makers in the Luxury sector. More concretely, our measure of the exclusivity of a brand takes into account the upper and more constant quality of products, the strong and unique valuation of the customer, the brand’s prestige, but also a matchless “savoir-faire” that justifies a very high price premium associated with top luxury. Finally, our measure of desirability synthesizes the dimensions of attractiveness of an intimate, social and symbolic nature, which are the strengths of exclusive brands, and characterize the particular relation that they maintain with their customers. In this respect, our Barometer synthesizes, in two proven scales, the numerous criteria to establish a ranking between the high-end brands from their customer’s point of view", states Pr. Philippe Jourdan, Promise’s CEO.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7727851-exclusivity-desirability-luxury-brands/
Pentair, Inc. (NYSE: PNR), a leader in sustainable water solutions, announced today the results of the multi-year Project Safewater-Colón initiative and research, funded by The Pentair Foundation. Project Safewater-Colón demonstrates that it’s possible to provide people in developing countries with affordable and sustainable sources of safe drinking water.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pentair/49765/
